Sense is developing non-invasive technology enabling rapid, comprehensive detection of stroke subtype + TBI, and continuous brain injury monitoring.
US FDA New Clinical for Sense Neuro Diagnostic
NEWS | May 18, 2023US FDA Approves New Clinical Trial for Sense Neuro DiagnosticsPivotal Study is Final Hurdle Before Commercialization; Will Focus on Validating Algorithm for Hemorrhage DetectionCINCINNATI, OH – May 18, 2023 – The U.S. Food and Drug Administration...
There is no accurate, objective way to detect stroke subtype or brain hemorrhage in a field environment or to monitor ongoing brain injury continuously, non-invasively and in real time.
Medical personnel must rely on an amalgam of information – clinical exams, vital signs, implanted ICP monitors – to determine whether the brain is bleeding between CT/MRI scans.
Non-invasive brain scanners that will assess and monitor the neurological status of a patient in real time.
Rapid triage and assessment for emergency departments and ambulance use
Nine antennae alternate transmitting and receiving a safe, low-power radio frequency (RF) pulse across the patient’s brain. Healthy brain tissues have unique electrical properties that alter the RF wave as it passes through the tissue. Similarly, hemorrhages and ischemic tissue cause distinctive changes to the RF signal.
Single scan in 2.5 seconds
360 data points per scan
Analyzes the entire cranial vault
Large vessel occlusion (LVO)
Traumatic brain injury
Experienced leadership team
Our team works diligently to make our innovative brain scanner a reality for patients. We are driven by our mission and are committed to impacting people's lives and enhancing neurological health globally.